The finding that HDAC1 and HDAC2 repress FBP1 expression in cultured HCC cells prompted us to determine whether expression of HDAC1 and HDAC2 inversely correlates with FBP1 levels in clinical samples. The gene discussed is FBP1; the disease is hepatocellular carcinoma.